Abstract

Hypertension is a major global health challenge, as it represents the main risk factor for stroke and cardiovascular disease. It is a multifactorial clinical condition characterized by high and sustained levels of blood pressure, likely resulting from a complex interplay of endogenous and environmental factors. The gut microbiota has been strongly supposed to be involved but its role in hypertension is still poorly understood. In an attempt to fill this gap, here we characterized the microbial composition of fecal samples from 48 hypertensive and 32 normotensive Brazilian individuals by next-generation sequencing of the 16S rRNA gene. In addition, the cytokine production of peripheral blood samples was investigated to build an immunological profile of these individuals. We identified a dysbiosis of the intestinal microbiota in hypertensive subjects, featured by reduced biodiversity and distinct bacterial signatures compared with the normotensive counterpart. Along with a reduction in Bacteroidetes members, hypertensive individuals were indeed mainly characterized by increased proportions of Lactobacillus and Akkermansia while decreased relative abundances of well-known butyrate-producing commensals, including Roseburia and Faecalibacterium within the Lachnospiraceae and Ruminococcaceae families. We also observed an inflamed immune profile in hypertensive individuals with an increase in TNF/IFN-γ ratio, and in TNF and IL-6 production when compared to normotensive ones. Our work provides the first evidence of association of hypertension with altered gut microbiota and inflammation in a Brazilian population. While lending support to the existence of potential microbial signatures of hypertension, likely to be robust to age and geography, our findings point to largely neglected bacteria as potential contributors to intestinal homeostasis loss and emphasize the high vulnerability of hypertensive individuals to inflammation-related disorders.

Highlights

  • MATERIALS AND METHODSHypertension is a major global health challenge, as it represents the main risk factor for stroke and cardiovascular disease, the number one cause of death worldwide, as well as for kidney disorders (Hillege et al, 2000; Mills et al, 2016; de Oliveira et al, 2017)

  • The identification of the causes of hypertension is still challenging but it is widely accepted that its etiology is multifactorial, involving an intricate set of endogenous and environmental factors contributing to its onset and progression

  • Consistent with recent findings in Chinese and United States cohorts (Li et al, 2017, 2019; Yan et al, 2017; Dan et al, 2019; Sun et al, 2019), our study highlighted a dysbiosis of the intestinal microbiota in hypertensive subjects, featured by reduced biodiversity and distinct bacterial signatures compared with the normotensive counterpart

Read more

Summary

MATERIALS AND METHODS

Hypertension is a major global health challenge, as it represents the main risk factor for stroke and cardiovascular disease, the number one cause of death worldwide, as well as for kidney disorders (Hillege et al, 2000; Mills et al, 2016; de Oliveira et al, 2017). This approach is able to detect subtle differences not detectable by conventional statistical analysis This categorical approach first converts the continuous cytokine measurements expressed in pg/ml into categorical variables, referred to as “Low” or “High” cytokine levels, taking the global median value as a specific cut-off edge for each cytokine. The inflammatory score was calculated based on three inflammatory cytokines, whose production was assessed as relevant in the HBP group according to the cytokine ratio (Figure 3) and signature analysis (Figure 4). To obtain such a score, the global median for each selected cytokine was calculated, and every value greater than the median gave 1 point to the subject. Scores 0 and 1 were categorized as “Not Inflamed” and scores 2 and 3 were categorized as “Inflamed.” the frequency of inflammatory score category for each group was calculated

RESULTS
DISCUSSION
ETHICS STATEMENT

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.